NCT07338032Completed
Task Specific Training and Conventional Physical Therapy on Ankle Dorsiflexion in Sub-acute Stroke Patients
Source: ClinicalTrials.gov · Last updated 13 Jan 2026
Brief summary (registry, in English)
This study is a randomized clinical trial designed to compare two physiotherapy rehabilitation approaches for people in the sub-acute phase after stroke (2-6 months after stroke). Stroke often causes weakness of the ankle dorsiflexor muscles, which can lead to foot drop and difficulty walking safely. Improving ankle control may help balance and functional mobility. Eligible participants will be recruited from two tertiary care hospitals using purposive sampling and enrolled after providing informed consent. After baseline assessment, participants will be randomly allocated to one of two groups. The experimental group will receive task-specific training combined with conventional physiotherapy, and the control group will receive conventional physiotherapy alone. Treatment will be delivered for 8 weeks, three sessions per week. Outcomes will be assessed at baseline and after completion of the 8-week intervention. The primary outcomes are ankle dorsiflexor strength measured by Manual Muscle Testing (MMT) and functional mobility measured by the Timed Up and Go (TUG) test. Balance measured by the Berg Balance Scale (BBS) is the secondary outcome. An independent outcome assessor who is not involved in treatment delivery will conduct the assessments to reduce measurement bias.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 66 (actual)
- First submitted
- 3 Jan 2026
- Start date
- Jun 2025
- Primary completion date
- Dec 2025
- Lead sponsor
- University of Lahore
- Diseases
- Stroke
- NCT number
- NCT07338032
What you commit to
- Study type: Interventional
- Participants enrolled: 66
- From Jun 2025 to the primary completion date, Dec 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Uncorrected vision and hearing loss or sensory impairment (Van Criekinge et al., 2022).
- Pain or musculoskeletal or any other neurological disorder (Srivastava et al., 2024).
Other
- Unilateral or Visual neglect (Van Criekinge et al., 2022).
- Sensory or global aphasia (Khallaf, 2020).
- Carcinoma (Srivastava et al., 2024).
Who the study is looking for
- Onset of stroke 2-6 months before study enrollment (Van Criekinge et al., 2022).
- Ability to walk with or without an assistive device (Khallaf, 2020).
- Presence of a minimum of 8-10 Degree of ankle plantarflexion-dorsiflexion range
- Ability to follow a three-step command, MMSE 24 (Srivastava et al., 2024).
- Spasticity of plantarflexers 1 or 1+ (Abd Elsabour et al., 2025).
- Not participating in any other form of physical rehabilitation. No lumber radiculopathy (Srivastava et al., 2024).
Age in the registry: 40 years to 65 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| The University of Lahore Teaching Hospital Coordinator of this site? Confirm its status | Lahore | Pakistan | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.